Các tế bào T điều hòa CD4+CD25+ ức chế miễn dịch chống ung thư nhưng nhạy cảm với cyclophosphamide, giúp liệu pháp miễn dịch chữa trị khối u hiện hành
Tóm tắt
Từ khóa
#CD4<sup>+</sup>CD25<sup>+</sup> #regulatory T cells #immunotherapy #tumor immunity #cyclophosphamide #immune tolerance #rat colon carcinomaTài liệu tham khảo
Sakaguchi S., 1995, Immunologic self tolerance maintained by activated T cells expressing IL2 receptor α chain (CD25). Breakdown of a single mechanism of self‐tolerance causes various autoimmune diseases., J. Immunol., 155, 1151, 10.4049/jimmunol.155.3.1151
Shimizu J., 1999, Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity., J. Immunol., 163, 5211, 10.4049/jimmunol.163.10.5211
Onizuka S., 1999, Tumor rejection by in vivo administration of anti‐CD25 (interleukin‐2 receptor alpha) monoclonal antibody., Cancer Res, 59, 3128
Steitz J., 2001, Depletion of CD25+CD4+ T cells and treatment with tyrosinase‐related protein 2‐transduced dendritic cells enhance the interferon‐α‐induced, CD8+ T cell‐dependent immune defense of B16 melanoma., Cancer Res., 61, 8643
Wolf A. M., 2003, Increase in regulatory T cells in the peripheral blood of cancer patients., Clin. Cancer Res., 9, 606
Bonnotte B., 1998, Bcl‐2‐mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicityof spontaneously regressive tumors., J. Immunol., 161, 1433, 10.4049/jimmunol.161.3.1433
Berd D., 1988, Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor‐inducer T cells., Cancer Res., 48, 1671